Cortland Associates Inc Johnson & Johnson Transaction History

Cortland Associates Inc

$760 Million
Q3 2024

A detailed history of Cortland Associates Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Cortland Associates Inc holds 2,008 shares of JNJ stock, worth $312,244. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,008

Previous 1,657 21.18%

Holding current value

$312,244

Previous $242,000 34.3%

% of portfolio

0.04%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$145.48 - $167.38 $51,063 - $58,750	351 Added 21.18%	2,008 $325,000
Q2 2024 Jul 29, 2024	BUY	$144.38 - $157.78 $144 - $157	1 Added 0.06%	1,657 $242,000
Q1 2024 Apr 22, 2024	SELL	$155.22 - $162.74 $11,486 - $12,042	-74 Reduced 4.28%	1,656 $261,000
Q4 2023 Jan 30, 2024	BUY	$145.6 - $158.88 $145 - $158	1 Added 0.06%	1,730 $271,000
Q3 2023 Oct 27, 2023	SELL	$155.75 - $174.48 $5,918 - $6,630	-38 Reduced 2.15%	1,729 $269,000
Q2 2023 Aug 03, 2023	BUY	$154.35 - $166.11 $154 - $166	1 Added 0.06%	1,767 $292,000
Q1 2023 Apr 20, 2023	SELL	$151.05 - $180.26 $24,923 - $29,742	-165 Reduced 8.54%	1,766 $273,000
Q4 2022 Jan 27, 2023	SELL	$160.2 - $179.79 $12,655 - $14,203	-79 Reduced 3.93%	1,931 $0
Q3 2022 Nov 01, 2022	BUY	$161.33 - $179.52 $5,969 - $6,642	37 Added 1.88%	2,010 $328,000
Q2 2022 Jul 22, 2022	BUY	$168.19 - $186.01 $27,583 - $30,505	164 Added 9.07%	1,973 $350,000
Q1 2022 May 03, 2022	SELL	$158.14 - $179.59 $5,376 - $6,106	-34 Reduced 1.84%	1,809 $321,000
Q4 2021 Feb 01, 2022	BUY	$155.93 - $173.01 $5,457 - $6,055	35 Added 1.94%	1,843 $315,000
Q3 2021 Nov 02, 2021	BUY	$161.5 - $179.47 $161 - $179	1 Added 0.06%	1,808 $292,000
Q2 2021 Aug 02, 2021	BUY	$159.48 - $171.07 $24,400 - $26,173	153 Added 9.25%	1,807 $298,000
Q1 2020 Apr 30, 2020	SELL	$111.14 - $153.99 $40,010 - $55,436	-360 Reduced 17.87%	1,654 $217,000
Q4 2019 Jan 31, 2020	BUY	$127.5 - $146.44 $40,417 - $46,421	317 Added 18.68%	2,014 $294,000
Q3 2019 Nov 07, 2019	SELL	$126.95 - $142.14 $38,085 - $42,641	-300 Reduced 15.02%	1,697 $220,000
Q1 2019 Apr 26, 2019	SELL	$125.72 - $139.79 $22,126 - $24,603	-176 Reduced 8.1%	1,997 $279,000
Q4 2018 Feb 01, 2019	BUY	$122.84 - $147.84 $11,055 - $13,305	90 Added 4.32%	2,173 $280,000
Q3 2018 Oct 30, 2018	SELL	$121.58 - $142.88 $232,947 - $273,758	-1,916 Reduced 47.91%	2,083 $288,000
Q2 2018 Jul 16, 2018	SELL	$119.4 - $131.76 $1,791 - $1,976	-15 Reduced 0.37%	3,999 $485,000
Q4 2017 Jan 24, 2018	BUY	$131.22 - $143.62 $78,732 - $86,172	600 Added 17.57%	4,014 $561,000
Q3 2017 Oct 25, 2017	BUY	$129.47 - $135.38 $442,010 - $462,187	3,414	3,414 $444,000

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $407B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cortland Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cortland Associates Inc with notifications on news.

Account

Cortland Associates Inc Johnson & Johnson Transaction History